Beating the Bio-Terror Threat with Rapid Antimicrobial Susceptibility Testing

A bioterror event using an infectious bacterium may lead to catastrophic outcomes involving morbidity and mortality as well as social and psychological stress. Moreover, a bioterror event using an antibiotic resistance engineered bacterial agent may raise additional concerns. Thus, preparedness is e...

Full description

Bibliographic Details
Main Authors: Shahar Rotem, Ida Steinberger-Levy, Ofir Israeli, Eran Zahavy, Ronit Aloni-Grinstein
Format: Article
Language:English
Published: MDPI AG 2021-07-01
Series:Microorganisms
Subjects:
Online Access:https://www.mdpi.com/2076-2607/9/7/1535
_version_ 1797526545316708352
author Shahar Rotem
Ida Steinberger-Levy
Ofir Israeli
Eran Zahavy
Ronit Aloni-Grinstein
author_facet Shahar Rotem
Ida Steinberger-Levy
Ofir Israeli
Eran Zahavy
Ronit Aloni-Grinstein
author_sort Shahar Rotem
collection DOAJ
description A bioterror event using an infectious bacterium may lead to catastrophic outcomes involving morbidity and mortality as well as social and psychological stress. Moreover, a bioterror event using an antibiotic resistance engineered bacterial agent may raise additional concerns. Thus, preparedness is essential to preclude and control the dissemination of the bacterial agent as well as to appropriately and promptly treat potentially exposed individuals or patients. Rates of morbidity, death, and social anxiety can be drastically reduced if the rapid delivery of antimicrobial agents for post-exposure prophylaxis and treatment is initiated as soon as possible. Availability of rapid antibiotic susceptibility tests that may provide key recommendations to targeted antibiotic treatment is mandatory, yet, such tests are only at the development stage. In this review, we describe the recently published rapid antibiotic susceptibility tests implemented on bioterror bacterial agents and discuss their assimilation in clinical and environmental samples.
first_indexed 2024-03-10T09:31:39Z
format Article
id doaj.art-9f7cb5184bac484ba9807e12b5fde85a
institution Directory Open Access Journal
issn 2076-2607
language English
last_indexed 2024-03-10T09:31:39Z
publishDate 2021-07-01
publisher MDPI AG
record_format Article
series Microorganisms
spelling doaj.art-9f7cb5184bac484ba9807e12b5fde85a2023-11-22T04:27:14ZengMDPI AGMicroorganisms2076-26072021-07-0197153510.3390/microorganisms9071535Beating the Bio-Terror Threat with Rapid Antimicrobial Susceptibility TestingShahar Rotem0Ida Steinberger-Levy1Ofir Israeli2Eran Zahavy3Ronit Aloni-Grinstein4Department of Biochemistry and Molecular Genetics, Israel Institute for Biological Research, Ness-Ziona 74100, IsraelDepartment of Biochemistry and Molecular Genetics, Israel Institute for Biological Research, Ness-Ziona 74100, IsraelDepartment of Biochemistry and Molecular Genetics, Israel Institute for Biological Research, Ness-Ziona 74100, IsraelDepartment of Biochemistry and Molecular Genetics, Israel Institute for Biological Research, Ness-Ziona 74100, IsraelDepartment of Biochemistry and Molecular Genetics, Israel Institute for Biological Research, Ness-Ziona 74100, IsraelA bioterror event using an infectious bacterium may lead to catastrophic outcomes involving morbidity and mortality as well as social and psychological stress. Moreover, a bioterror event using an antibiotic resistance engineered bacterial agent may raise additional concerns. Thus, preparedness is essential to preclude and control the dissemination of the bacterial agent as well as to appropriately and promptly treat potentially exposed individuals or patients. Rates of morbidity, death, and social anxiety can be drastically reduced if the rapid delivery of antimicrobial agents for post-exposure prophylaxis and treatment is initiated as soon as possible. Availability of rapid antibiotic susceptibility tests that may provide key recommendations to targeted antibiotic treatment is mandatory, yet, such tests are only at the development stage. In this review, we describe the recently published rapid antibiotic susceptibility tests implemented on bioterror bacterial agents and discuss their assimilation in clinical and environmental samples.https://www.mdpi.com/2076-2607/9/7/1535bioterror<i>Bacillus anthracis</i><i>Yersinia pestis</i><i>Francisella tularensis</i>antibioticclinical samples
spellingShingle Shahar Rotem
Ida Steinberger-Levy
Ofir Israeli
Eran Zahavy
Ronit Aloni-Grinstein
Beating the Bio-Terror Threat with Rapid Antimicrobial Susceptibility Testing
Microorganisms
bioterror
<i>Bacillus anthracis</i>
<i>Yersinia pestis</i>
<i>Francisella tularensis</i>
antibiotic
clinical samples
title Beating the Bio-Terror Threat with Rapid Antimicrobial Susceptibility Testing
title_full Beating the Bio-Terror Threat with Rapid Antimicrobial Susceptibility Testing
title_fullStr Beating the Bio-Terror Threat with Rapid Antimicrobial Susceptibility Testing
title_full_unstemmed Beating the Bio-Terror Threat with Rapid Antimicrobial Susceptibility Testing
title_short Beating the Bio-Terror Threat with Rapid Antimicrobial Susceptibility Testing
title_sort beating the bio terror threat with rapid antimicrobial susceptibility testing
topic bioterror
<i>Bacillus anthracis</i>
<i>Yersinia pestis</i>
<i>Francisella tularensis</i>
antibiotic
clinical samples
url https://www.mdpi.com/2076-2607/9/7/1535
work_keys_str_mv AT shaharrotem beatingthebioterrorthreatwithrapidantimicrobialsusceptibilitytesting
AT idasteinbergerlevy beatingthebioterrorthreatwithrapidantimicrobialsusceptibilitytesting
AT ofirisraeli beatingthebioterrorthreatwithrapidantimicrobialsusceptibilitytesting
AT eranzahavy beatingthebioterrorthreatwithrapidantimicrobialsusceptibilitytesting
AT ronitalonigrinstein beatingthebioterrorthreatwithrapidantimicrobialsusceptibilitytesting